DRWA 2026 agenda
DRWA 2026 agenda
DRWA 2026: Thirteenth Annual Conference – Comprehensive Science Agenda and Key Sessions on Cardiometabolic Health
Overview of the DRWA 2026 Agenda and What to Expect
The DRWA 2026 conference brings together researchers, clinicians, and policymakers for three days of in-depth sessions focused on metabolic health, diabetes management, and cardiometabolic disease. The event runs from May 29 to May 31, 2026, with a virtual scientific program on May 29 and in-person sessions scheduled at the BISWA Bangla Convention Centre in Kolkata. The virtual program features concise presentations followed by brief question-and-answer periods, designed to maximize knowledge exchange across the online audience. Page: N/A
On the opening day of virtual science, participants will hear a lineup of focused talks addressing a wide range of topics relevant to diabetes and metabolic disorders. Each speaker delivers a compact 15-minute talk, followed by a short Q&A window, covering subjects from pregnancy-related thyroid issues to new approaches in wound care for diabetes. Thematic threads connect these talks, emphasizing translational insights and practical implications for patient care in 2026. Page: N/A
A notable portion of the program centers on endocrine and metabolic interactions, with discussions on how hormonal signals influence metabolic health, the role of nutritional strategies in diabetes, and the impact of emerging therapies on cardiovascular risk. Topics span from thyroid activity in pregnancy to the evolving landscape of diabetes risk management, highlighting the conference’s integration of basic science, clinical practice, and digital health innovations. Page: N/A
Beyond disease mechanisms, the agenda also foregrounds technology and data-driven care. Presentations explore artificial intelligence in risk prediction and management, the potential and limitations of closed-loop insulin delivery, and the integration of real-world evidence from digital health platforms to inform practice in diverse settings. Page: N/A
The program includes practical and clinical concerns such as the role of pioglitazone in contemporary diabetes care, advances in artificial pancreas technology, and contemporary debates about statin and aspirin use in type 2 diabetes. Attendees will also encounter discussions on oral health’s relationship to diabetes, magnesium status in cardiometabolic disorders, and the evolving dyslipidemia paradigm for 2025–26. Page: N/A
In addition to traditional sessions, the agenda features a series of case-based talks and expert perspectives that illuminate how comorbid conditions intersect with diabetes management. Examples include exploring how obesity interacts with metabolic disease, and examining adolescent diabetes through a contemporary lens. The aim is to present a holistic view of patient care that spans ages, comorbidities, and health system contexts. Page: N/A
The conference also spotlights the people behind the science, with esteemed chairpersons and session leaders guiding discussions and helping to frame clinical relevance for practicing physicians, researchers, and trainees. This leadership structure is designed to foster collaborative dialogue and practical takeaways that attendees can translate into clinical or research settings. Page: N/A
Moving from the virtual day to the in-person program, the Day 1 agenda shifts to a broad exploration of the metabolic nexus, beginning with global and continuum perspectives on cardiometabolic disease. Sessions address the global burden, the progression from insulin resistance to diabetes, and how pharmacogenomics can tailor glycemic management to individual patients. Page: N/A
The Day 1 schedule also includes a dedicated flow on the societal dimensions of metabolic disease, emphasizing how poverty, stress, and urbanization shape risk. Further talks examine food environments and the crisis of ultra-processed foods, along with community-based prevention strategies. The program recognizes mental health as a key component of metabolic health, illustrating the bidirectional connections between diabetes and psychological well-being. Page: N/A
Beyond prevention, the agenda features discussions on organ systems and therapeutic innovations. Attendees will hear about heart-kidney-liver interactions in metabolic risk, including the use of SGLT2 inhibitors for cardiorenal protection and the pathophysiology of diabetic cardiomyopathy. The latest guidelines for managing diabetic kidney disease are presented, alongside the exploration of novel therapies that may reshape care in 2026. Page: N/A
As the conference unfolds, there are formal orations and special sessions that spotlight outstanding contributors and landmark ideas. The B C Roy Oration and the presidential oration are designed to highlight leadership in the field and to inspire attendees with high-level scientific narratives, complemented by a program of translational and clinical discussions that bridge research and practice. Page: N/A
Therapeutic innovations take center stage in another core set of talks, where advances such as GIP/GLP-1 dual agonists (twincretins), oral insulin approaches, and the use of multi-omics in personalized prevention are explored. These sessions emphasize how cutting-edge science could translate into more precise and effective interventions for diverse patient populations. Page: N/A
Diabetes in special populations receives focused attention, including management gaps in adult-onset type 1 diabetes, individualized targets for elderly patients, and strategies to address childhood obesity and early metabolic programming. By addressing these distinct groups, the program underscores the need for tailored approaches across the lifespan. Page: N/A
Keynote lectures form another pillar of Day 1, featuring discussions on monogenic diabetes and modern cardioprotection evidence, with perspectives on how emerging data can change clinical decision-making. The agenda also touches on the role of chronic low-grade inflammation as a unifying thread in metabolic syndrome and includes a debate on obesity as a disease, lifestyle factor, or industry-driven phenomenon. Page: N/A
The festive and formal elements of the conference include an inauguration ceremony and a dedicated DRWA Oration, designed to recognize outstanding contributors and to set a collegial tone for collaborative work. These moments complement the scientific program by reinforcing professional camaraderie and shared goals for advancing metabolic health. Page: N/A
Environmental and hormonal interactions occupy a prominent place, with sessions on endocrine disruptors’ links to metabolic disease and the cross-talk between thyroid function and diabetes. These topics illustrate the broader environmental and physiological context in which metabolic disorders develop and persist, reinforcing the importance of a multidisciplinary approach to prevention and treatment. Page: N/A
Technology, digital health, and diabetes management remain central themes, covering closed-loop insulin delivery systems, risk prediction through AI, real-world evidence from digital platforms, and the expansion of telehealth and mobile health to reduce disparities between rural and urban care. The program highlights practical uptake of digital health tools while acknowledging challenges and limitations. Page: N/A
In addition to the primary halls, Day 1 features a parallel set of activities in another hall, including a broad array of keynote talks, panel discussions, and practical sessions within the field of diabetic care and metabolic health. The programming is designed to facilitate deep dives into topics while offering opportunities for cross-panel interaction and audience engagement. Page: N/A
A notable segment of Day 1 is the Diaccon program, which gathers experts for rapid-fire sessions, keynote talks, and panel discussions focused on scalable solutions for metabolic disease control. The day also includes coordinated discussions on circadian biology, hypertension management in insulin-resistant states, and sex-specific metabolic pathways, each framed to inform clinical practice with cutting-edge science. Page: N/A
The program continues with practical discourses on diabesity—the intersection of obesity and diabetes—as well as physician-led solutions for metabolic health equity. These elements reflect a drive toward real-world impact, emphasizing scalable, evidence-based strategies that can be implemented across diverse healthcare settings. Page: N/A
SpecialSymposium 1 on Tirzepatide provides a concentrated look at this emerging therapy, with sessions around surpassing standard care in type 2 diabetes, managing obesity beyond conventional thresholds, and translating trial results into routine clinical practice. A concluding panel discussion invites broader expert input, enriching the conversation with varied perspectives from the diabetes care community. Page: N/A
As the Day 1 program concludes, attendees are invited to explore more content through Flipbook Gallery resources, which offer additional magazines, catalogs, reports, and related materials. The event’s digital footprint reinforces knowledge sharing beyond the live program and encourages ongoing engagement with the conference’s themes. Page: N/A
